Takeda Pharmaceutical Co., Ltd (NYSE:TAK) on Thursday announced positive topline results for the two pivotal Phase 3 studies of zasocitinib (TAK-279) for moderate-to-severe plaque psoriasis (PsO).DataThe studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoi... Read more
Benzinga - Dec 18
SPRING HOUSE, PA — A new U.S. study from Johnson & Johnson (NYSE: JNJ) reveals that most people living with psoriasis — and their healthcare providers — strongly prefer effective ... Read more
Mychesco - Nov 08
The 'Kardashians' star revealed having a minor brain aneurysm caused of stress. Since this wasn't Kim's first health issue, here's a look back at the challenges she's faced. Read more
Hollywood Life - Oct 23
A mutation previously linked to skin disorders like psoriasis may also play a surprising role in gut health, according to new research published by scientists at VIB-UGent and colleagues from UGent, the University of Barcelona, and University College London. Read more
Medical News - Oct 23
Apple is the most common body shape in the UK today - and also the most deadly, researchers are now warning. Read more
Mail Online - Sep 09
